Nivolumab/pembrolizumabVarious toxicities: 9 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1758卷 / 1期

关键词：

D O I：

10.1007/s40278-019-63804-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[1] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2020, 1806 (1) : 59 - 59
[2] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2018, 1704 (1) : 209 - 210
[3] Ipilimumab/Nivolumab/PembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2025, 2048 (1) : 209 - 209
[4] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2020, 1800 (1) : 181 - 181
[5] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1848 (1) : 310 - 310
[6] Nivolumab/pembrolizumabVarious toxicities: 116 case reports
Reactions Weekly, 2016, 1611 (1) : 132 - 132
[7] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1786 (1) : 131 - 131
[8] Nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1858 (1) : 314 - 314
[9] Nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1858 (1) : 313 - 313
[10] Nivolumab/pembrolizumabVarious toxicities: 92 case reports
Reactions Weekly, 2016, 1611 (1) : 133 - 133

← 1 2 3 4 5 →